Investment thesis
I’ve stated my base case regarding the uncertain business environment for the cannabis/marijuana sector in each of the five articles I’ve written here at SeekingAlpha. The upcoming industry shakeout will materially affect valuations and may result in widespread consolidation and business failures. I am now more pessimistic about the next six to nine months as there is more evidence that the oversupply of product will negatively affect the price of cannabis in 2020.
In my view Medicine Man Technologies, Inc. (MDCL) is among the most vulnerable stocks in the sector